Alvotech (ALVO) Dividends Paid - Common (2022 - 2026)
Alvotech's (ALVO) quarterly Dividends Paid - Common came in at $63.8 million in Q1 2026, up 65.61% YoY from $38.5 million in Q1 2025, and up 142.16% on a QoQ basis from -$151.4 million in Q3 2025.
Alvotech (ALVO) Dividends Paid - Common (2022 - 2026) Analysis & Trends
Alvotech (ALVO) has 5 years of Dividends Paid - Common data on file, last reported at $63.8 million in Q1 2026.
- Quarterly Dividends Paid - Common rose 65.61% year-over-year to $63.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.9 million (up 152.68% YoY) and the FY2023 annual result came in at $11.2 million, changed N/A from the prior year.
- Dividends Paid - Common advanced to $63.8 million in Q1 2026, from -$151.4 million in the prior quarter.
- In the past five years, Dividends Paid - Common ranged from a high of $115.8 million in Q1 2023 to a low of -$151.4 million in Q3 2025.
- A 5-year average of $21.1 million and a median of $45.0 million in 2024 frame the typical range for Dividends Paid - Common.
- Annual changes were most pronounced in 2024 — Dividends Paid - Common jumped 360.95% — and 2025, when it sank 1298.61%.
- Tracing ALVO's Dividends Paid - Common over 5 years: stood at $66.4 million in 2022, then slumped by 83.2% to $11.2 million in 2023, then surged by 360.95% to $51.4 million in 2024, then plunged by 394.41% to -$151.4 million in 2025, then soared by 142.16% to $63.8 million in 2026.
- The last three Dividends Paid - Common figures came in at $63.8 million (Q1 2026), -$151.4 million (Q3 2025), and $112.9 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 223.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -941.91 Mn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 139.80 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Alvotech | 1.23 Bn | 1.23 Bn | 5.09 Mn | 63.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.83 Mn |
| Mar 31, 2026 | 63.83 Mn |
| Sep 30, 2025 | -151.41 Mn |
| Sep 30, 2025 | -151.41 Mn |
| Jun 30, 2025 | 112.91 Mn |
| Jun 30, 2025 | 112.91 Mn |
| Mar 31, 2025 | 38.54 Mn |
| Mar 31, 2025 | 38.54 Mn |
| Dec 31, 2024 | 51.43 Mn |
| Dec 31, 2024 | 51.43 Mn |
| Sep 30, 2024 | -10.83 Mn |
| Sep 30, 2024 | -10.83 Mn |
| Jun 30, 2024 | -53.87 Mn |
| Jun 30, 2024 | -53.87 Mn |
| Mar 31, 2024 | 64.81 Mn |
| Mar 31, 2024 | 64.81 Mn |
| Dec 31, 2023 | 11.16 Mn |
| Dec 31, 2023 | 11.16 Mn |
| Jun 30, 2023 | -55.38 Mn |
| Jun 30, 2023 | -55.38 Mn |